Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 6NIH 3INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Glioblastoma 94Glioma 32Brain Neoplasms 29Melanoma 21Neoplasms 17Astrocytoma 17Sarcoma, Ewing 7Ovarian Neoplasms 7Gliosarcoma 7Carcinoma, Non-Small-Cell Lung 7Neuroblastoma 6Neoplasm Metastasis 6Medulloblastoma 6Breast Neoplasms 6Sarcoma 5Recurrence 5Diffuse Intrinsic Pontine Glioma 5Small Cell Lung Carcinoma 4Rhabdomyosarcoma 4Oligodendroglioma 4Spinal Cord Neoplasms 3Prostatic Neoplasms 3Pancreatic Neoplasms 3Central Nervous System Neoplasms 3Triple Negative Breast Neoplasms 2Rhabdoid Tumor 2Neuroendocrine Tumors 2Lymphoma, Follicular 2Head and Neck Neoplasms 2Fallopian Tube Neoplasms 2

Interventions

Pemetrexed 3mifamurtide 2lenvatinib 2dostarlimab 2belinostat 2Ifosfamide 2Granulocyte-Macrophage Colony-Stimulating Factor 2Gemcitabine 2Etoposide 2Drug Therapy 2Cyclophosphamide 2Cisplatin 2vactosertib 1surufatinib 1sintilimab 1robatumumab 1ridaforolimus 1reolysin 1pembrolizumab 1pazopanib 1omburtamab I-131 1niraparib 1isophosphamide mustard 1fludarabine 1endostar protein 1dinutuximab 1copanlisib 1cc-486 1cabozantinib 1anlotinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Osteosarcoma × Temozolomide × Clear all
NCT04238819 2026-03-02

A Study of Abemaciclib (LY2835219) in Combination With Other Anti-Cancer Treatments in Children and Young Adult Participants With Solid Tumors, Including Neuroblastoma

Eli Lilly and Company

Phase 1/2 Completed
47 enrolled 36 charts
CNSSarcoma

Diffuse Intrinsic Pontine Glioma, Brain Neoplasms, Ependymoma, Glioblastoma, Glioma, Medulloblastoma, Neuroblastoma, Rhabdomyosarcoma, Sarcoma, Ewing, Osteosarcoma, Rhabdoid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡